J. B. Chemicals & Pharmaceuticals Limited Stock NSE India S.E.
Equities
JBCHEPHARM
INE572A01036
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,901 INR | +1.92% | +6.35% | +17.04% |
Sales 2024 * | 35.01B 420M | Sales 2025 * | 40.58B 486M | Capitalization | 289B 3.47B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.58M | Net income 2025 * | 7.06B 84.62M | EV / Sales 2024 * | 8.3 x |
Net Debt 2024 * | 1.32B 15.8M | Net cash position 2025 * | 4.41B 52.89M | EV / Sales 2025 * | 7.02 x |
P/E ratio 2024 * |
48.4
x | P/E ratio 2025 * |
38.7
x | Employees | 5,095 |
Yield 2024 * |
0.65% | Yield 2025 * |
0.77% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +1.95% | ||
1 week | +6.35% | ||
Current month | +15.21% | ||
1 month | +12.14% | ||
3 months | +12.19% | ||
6 months | +36.61% | ||
Current year | +17.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1,901 | +1.92% | 55 721 |
24-04-26 | 1,865 | +0.12% | 72,657 |
24-04-25 | 1,863 | +2.10% | 191,404 |
24-04-24 | 1,825 | +2.26% | 133,182 |
24-04-23 | 1,784 | -0.21% | 113,740 |
Delayed Quote NSE India S.E., April 29, 2024 at 05:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.23% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.60% | 231B | |
+5.04% | 200B | |
-9.37% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- JBCHEPHARM Stock
- JBCHEPHARM Stock